Suivre
David H. Gutmann, MD, PhD
David H. Gutmann, MD, PhD
Donald O. Schnuck Family Professor, Washington University School of Medicine
Adresse e-mail validée de wustl.edu
Titre
Citée par
Citée par
Année
The somatic genomic landscape of glioblastoma
CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ...
cell 155 (2), 462-477, 2013
49212013
Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma
M Ceccarelli, FP Barthel, TM Malta, TS Sabedot, SR Salama, BA Murray, ...
Cell 164 (3), 550-563, 2016
19832016
The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2
DH Gutmann, A Aylsworth, JC Carey, B Korf, J Marks, RE Pyeritz, ...
Jama 278 (1), 51-57, 1997
16471997
The role of microglia and macrophages in glioma maintenance and progression
D Hambardzumyan, DH Gutmann, H Kettenmann
Nature neuroscience 19 (1), 20-27, 2016
13792016
Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis
K Yamanaka, SJ Chun, S Boillee, N Fujimori-Tonou, H Yamashita, ...
Nature neuroscience 11 (3), 251-253, 2008
12982008
Subtypes of medulloblastoma have distinct developmental origins
P Gibson, Y Tong, G Robinson, MC Thompson, DS Currle, C Eden, ...
Nature 468 (7327), 1095-1099, 2010
9262010
Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients
TN Basu, DH Gutmann, JA Fletcher, TW Glover, FS Collins, J Downward
Nature 356 (6371), 713-715, 1992
8051992
Neurofibromatosis type 1 revisited
VC Williams, J Lucas, MA Babcock, DH Gutmann, B Korf, BL Maria
Pediatrics 123 (1), 124-133, 2009
7962009
Comprehensive and integrated genomic characterization of adult soft tissue sarcomas
AJ Lazar, MD McLellan, MH Bailey, CA Miller, EL Appelbaum, MG Cordes, ...
Cell 171 (4), 950-965, 2017
7902017
International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis
RE Ferner, DH Gutmann
Cancer research 62 (5), 1573-1577, 2002
7632002
Neurofibromatosis type 1
DH Gutmann, RE Ferner, RH Listernick, BR Korf, PL Wolters, KJ Johnson
Nature Reviews Disease Primers 3 (1), 1-17, 2017
7552017
The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44
H Morrison, LS Sherman, J Legg, F Banine, C Isacke, CA Haipek, ...
Genes & development 15 (8), 968-980, 2001
6692001
Challenges to curing primary brain tumours
K Aldape, KM Brindle, L Chesler, R Chopra, A Gajjar, MR Gilbert, ...
Nature reviews Clinical oncology 16 (8), 509-520, 2019
6682019
Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex
LH Zeng, L Xu, DH Gutmann, M Wong
Annals of Neurology: Official Journal of the American Neurological …, 2008
6592008
Optic pathway gliomas in neurofibromatosis‐1: controversies and recommendations
R Listernick, RE Ferner, GT Liu, DH Gutmann
Annals of Neurology: Official Journal of the American Neurological …, 2007
6402007
Neurofibromatosis type 1: a multidisciplinary approach to care
AC Hirbe, DH Gutmann
The Lancet Neurology 13 (8), 834-843, 2014
5962014
Neurofibromatosis 1
JM Friedman
5672022
Cellular and molecular identity of tumor-associated macrophages in glioblastoma
Z Chen, X Feng, CJ Herting, VA Garcia, K Nie, WW Pong, R Rasmussen, ...
Cancer research 77 (9), 2266-2278, 2017
5532017
Optic pathway gliomas in children with neurofibromatosis 1: consensus statement from the NF1 Optic Pathway Glioma Task Force
R Listernick, DN Louis, RJ Packer, DH Gutmann
Annals of Neurology: Official Journal of the American Neurological …, 1997
5521997
Microglia states and nomenclature: A field at its crossroads
RC Paolicelli, A Sierra, B Stevens, ME Tremblay, A Aguzzi, B Ajami, I Amit, ...
Neuron 110 (21), 3458-3483, 2022
5342022
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20